HealthIntro - Health Perspective in the Introduction Program

NCT ID: NCT04973215

Last Updated: 2021-07-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-10-31

Study Completion Date

2025-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Health problems seem one major reason for why not all refugees, especially women, fulfill the introduction program (IP) and enter the labour market after the end of the program. This challenges integration, and can lead to increased inequalities in society. The HealthIntro pilot-project and existing knowledge point towards a mismatch between the IP's goal to integrate as many refugees as possible into the labour market as soon as possible, and the demanding situation refugees with complex (health) challenges face after resettlement in the host country. Particular barriers seem related to the little flexibility of the introduction law, difficulties with collaboration between public services and with involving refugees in decision-making regarding program adjustments. It is known that refugees have more health problems than the rest of the population. Additionally, current trends in integration policy result in increasing numbers of refugees with complex challenges in municipalities, often families in which one or several members have health problems. It is therefore of high importance to develop strategies that enable municipalities to work more effectively with these most vulnerable group of refugees in the early phase of resettlement and during the IP.

In collaboration with three North Norwegian municipalities and refugees, the investigators will explore how health problems interconnect with program participation on the national level, the municipal level and in a family context. Moreover, the investigators will use this knowledge to collaboratively generate ideas on how to improve the strategic work in municipalities with refugees with health problems. More specifically, the investigators will link registerdata on a national level, conduct explorative qualitative studies addressing the system level in municipalities, and the family and everday life context of refugee families, and conduct an action research inspired study to initiating change in municipalities.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is funded by The Norwegian Research Council (project number 319050)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Refugee Health

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

work package 1

all participants in Norwegian introduction program and their family relations

no intervention

Intervention Type OTHER

this is not an intervention study

work package 2

strategic sample of refugees with health problems currently participating in the introduction program

no intervention

Intervention Type OTHER

this is not an intervention study

work package 3

3-6 families from which one or more participate in the introduction program and one or more have health problems

no intervention

Intervention Type OTHER

this is not an intervention study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

no intervention

this is not an intervention study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* refugee status
* participate or have participated in the introduction program in Norway


* refugee status
* participate in the introduction program in Harstad, Senja, or Sør-Varanger municipality during the project period and since at least one year at enrollment
* have a self-reported health problem


* has professional experience with refugees in Harstad, Senja, or Sør-Varanger municipality
* currently working in Harstad, Senja, or Sør-Varanger municipality
* above 18 years of age


* refugee status
* living together with family including one or more children
* participate in the introduction program in Harstad, Senja, or Sør-Varanger municipality during the project period and since at least one year at enrollment
* have a self-reported health problem within the family

Exclusion Criteria

* not refugee status
* not participated in the introduction program in Norway

Work package 2:


* no refugee status
* do not participate in the introduction program
* do not have a health problem


* under 18 years of age
* not currently working in Harstad, Senja, or Sør-Varanger municipality

Work package 3:


* no refugee status
* do not participate in the introduction program
* do not live together with family
* do not have a health problem within the family
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

NORCE Norwegian Research Centre AS

OTHER

Sponsor Role collaborator

FAFO Research foundation

UNKNOWN

Sponsor Role collaborator

Harstad municipality

UNKNOWN

Sponsor Role collaborator

Senja municipality

UNKNOWN

Sponsor Role collaborator

Sør-Varanger municipality

UNKNOWN

Sponsor Role collaborator

University of Tromso

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Johanna Laue

associate professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Johanna Laue

Role: CONTACT

004796237993

Sindre Myhr

Role: CONTACT

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

237875

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.